[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fZIm8OcM9qnCPbBszIqtxfXS_t-SrIFmD3tBW-_JHeew":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":13,"question":20,"related":21,"source":25,"type":26},[],"2025-12-25 00:37:36",259055654,[8,9,10,11,12],"硅橡胶","脂肪","聚乙烯","海藻酸钠","蜡类",{"count":14,"courseId":15,"courseImg":16,"courseName":17,"workId":18,"workName":19},110,"53e1d2ef4961cca8eea3e23969ad2cb9","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F03a579384a6dc297c89809b582fcc767.png","默认课程","work_48766898","第十三章 缓释、控释和迟释制剂(在线升级)","亲水性凝胶骨架片的材料为( )",[22,27,37,47,57,67,77,87,97,107],{"answer":23,"createTime":5,"id":6,"options":24,"question":20,"source":25,"type":26},[],[8,9,10,11,12],"v1",0,{"answer":28,"createTime":5,"id":29,"options":30,"question":36,"source":25,"type":26},[],259055655,[31,32,33,34,35],"无毒聚氯乙烯","单棕榈酸甘油脂","卡波姆","乙基纤维素","甲基纤维素","可用于溶蚀性骨架片的材料为( )",{"answer":38,"createTime":5,"id":39,"options":40,"question":46,"source":25,"type":26},[],259055656,[41,42,43,44,45],"无要求","小于1.0mg\u002Fml","小于10mg\u002Fml","小于0.01mg\u002Fml","小于0.1mg\u002Fml","设计缓(控)释制剂对药物溶解度的要求一般为( )",{"answer":48,"createTime":5,"id":49,"options":50,"question":56,"source":25,"type":26},[],259055657,[51,52,53,54,55],"油水分配系数","水溶性","稳定性","生物半衰期","pKa解离度","影响口服缓控释制剂的设计的理化因素不包括( )",{"answer":58,"createTime":5,"id":59,"options":60,"question":66,"source":25,"type":26},[],259055658,[61,62,63,64,65],"植入剂","包衣","胃内滞留型","药树脂","微囊","不是以减小扩散速度为主要原理的制备缓、控释制剂的工艺是( )",{"answer":68,"createTime":5,"id":69,"options":70,"question":76,"source":25,"type":26},[],259055659,[71,72,73,74,75],"生物粘附片","渗透泵型片","胃内滞留片","微孔膜包衣片","溶蚀性骨架片","哪种属于膜控型缓控释制剂( )",{"answer":78,"createTime":5,"id":79,"options":80,"question":86,"source":25,"type":26},[],259055660,[81,82,83,84,85],"渗透泵型片剂工艺较难,价格较贵","半渗透膜的厚度、渗透性、片芯的处方、释药小孔的直径是制备渗透泵的关键","渗透泵型片剂以零级释药,为控释制剂","渗透泵型片剂与包衣片剂很相似,只是在包衣片剂的一端用激光开一细孔,药物由细孔流出","渗透泵型片剂的释药速度与pH无关,在胃内与肠内的释药速度相等","关于渗透泵型控释制剂,错误的叙述为( )",{"answer":88,"createTime":5,"id":89,"options":90,"question":96,"source":25,"type":26},[],259055661,[91,92,93,94,95],"3-4","2-3","1-2","4-5","5-6","胃内滞留片一般可在胃内滞留( )小时",{"answer":98,"createTime":5,"id":99,"options":100,"question":106,"source":25,"type":26},[],259055662,[101,102,103,104,105],"5个","2个","1个","4个","3个","缓、控释制剂的体外释放度至少应测( )个取样点",{"answer":108,"createTime":5,"id":109,"options":110,"question":114,"source":25,"type":26},[],259055663,[72,111,112,75,113],"不溶性骨架片","膜控片","亲水凝胶骨架片","哪种缓控释制剂可采用熔融技术制粒后压片( )"]